CEO SUMMARY: This year’s list of the Top 10 Lab Industry Stories for 2018 is dominated by new directives from Medicare and private health insurers, as well as significant decisions by federal courts. Collectively, these developments create new compliance risks for all clinical laboratories and anatomic pathology groups. What is more notable about these top …
2019 Outlook: Lab Industry Future Looks Dire, From Reactions to Recent Medicare Fraud Cases to PAMA Reporting and Other Stress Factors
Pressures generated by recent Medicare fraud cases account for four of Top 10 stories of 2018
- By Mary Van Doren
- | From the Volume XXV No. 18 - December 24, 2018 Issue
- Tags: Anatomic pathology, clinical lab, clinical laboratories, Clinical Laboratory, Clinical Laboratory Fee Schedule, clinical labs, compliance requirements, digital pathology, digital pathology system, genetic tests, lab business, lab industry, lab test, lab test prices, lab testing, lab tests, laboratories, laboratory fee schedule, Medicare, medicare fraud cases, Medicare Part B, outreach lab, pathologists, pathology groups, pathology practice, private payer, recent medicare fraud cases
